Foothills Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Foothills Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$1.88M	Sell	24,239 -1,970	-8%	-$174K	1.63%	24
2019 Q4	$2.49M	Buy	26,209 +493	+2%	+$42.6K	1.78%	23
2019 Q3	$1.96M	Buy	25,716 +84	+0.3%	+$6.98K	1.48%	34
2019 Q2	$2.25M	Sell	25,632 -631	-2%	-$53.8K	1.74%	25
2019 Q1	$2.38M	Sell	26,263 -367	-1%	-$31.2K	1.84%	23
2018 Q4	$1.91M	Sell	26,630 -140	-0.5%	-$11.3K	1.63%	28
2018 Q3	$2.57M	Sell	26,770 -1,100	-4%	-$107K	1.97%	20
2018 Q2	$2.65M	Sell	27,870 -351	-1%	-$32.3K	2.03%	19
2018 Q1	$2.48M	Sell	28,221 -1,384	-5%	-$126K	1.94%	19
2017 Q4	$2.51M	Sell	29,605 -1,655	-5%	-$139K	1.91%	22
2017 Q3	$2.71M	Sell	31,260 -225	-0.7%	-$18K	2.03%	15
2017 Q2	$2.43M	Sell	31,485 -115	-0.4%	-$8.16K	1.89%	23
2017 Q1	$2.19M	Sell	31,600 -1,810	-5%	-$122K	1.72%	33
2016 Q4	$1.98M	Sell	33,410 -1,125	-3%	-$69.4K	1.52%	35
2016 Q3	$2.29M	Buy	+34,535	New	+$2.14M	1.73%	29

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $57.2B AUM 35.3% 1-Year Est. Return

Foothills Asset Management's XBI Position: Q1 2020 in Review

Foothills Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 7.5% in Q1 2020, selling an estimated $174K and leaving 24,239 shares worth $1.88M. The position accounts for 1.63% of the portfolio, ranked #24.

Foothills Asset Management first reported a position in XBI in Q3 2016 and has held it in 15 quarters since. The position peaked at $2.71M in Q3 2017. 459 funds tracked by Wall St. Rank hold XBI as of Q1 2020.

Foothills Asset Management held 24,239 shares of State Street SPDR S&P Biotech ETF worth $1.88M as of Q1 2020.
Foothills Asset Management sold 1,970 State Street SPDR S&P Biotech ETF shares in Q1 2020, an estimated $174K.
State Street SPDR S&P Biotech ETF made up 1.63% of Foothills Asset Management's portfolio in Q1 2020, its #24 holding.
Foothills Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and has held it in 15 quarters since.
Foothills Asset Management's State Street SPDR S&P Biotech ETF position peaked at $2.71M in Q3 2017.
459 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2020.

Based on Foothills Asset Management's 13F filing for Q1 2020, filed 15 Apr 2020.